Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apyx Medical (APYX) Preferred Shares (2016 - 2017)

Apyx Medical (APYX) has disclosed Preferred Shares for 5 consecutive years, with $1000.0 as the latest value for Q2 2017.

  • For the quarter ending Q2 2017, Preferred Shares fell 50.0% year-over-year to $1000.0, compared with a TTM value of $1000.0 through Jun 2017, down 50.0%, and an annual FY2016 reading of $1000.0, down 50.0% over the prior year.
  • Preferred Shares was $1000.0 for Q2 2017 at Apyx Medical, roughly flat from $1000.0 in the prior quarter.
  • Across five years, Preferred Shares topped out at $3.2 million in Q4 2014 and bottomed at $1000.0 in Q4 2016.
  • Average Preferred Shares over 5 years is $645769.2, with a median of $2000.0 recorded in 2015.
  • The sharpest move saw Preferred Shares surged 41.21% in 2014, then crashed 99.94% in 2015.
  • Year by year, Preferred Shares stood at $2.3 million in 2013, then skyrocketed by 41.21% to $3.2 million in 2014, then plummeted by 99.94% to $2000.0 in 2015, then crashed by 50.0% to $1000.0 in 2016, then changed by 0.0% to $1000.0 in 2017.
  • Business Quant data shows Preferred Shares for APYX at $1000.0 in Q2 2017, $1000.0 in Q1 2017, and $1000.0 in Q4 2016.